S

Stille AB
STO:STIL

Watchlist Manager
Stille AB
STO:STIL
Watchlist
Price: 203 SEK -1.93% Market Closed
Market Cap: 1.8B SEK
Have any thoughts about
Stille AB?
Write Note

Stille AB
Other Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Stille AB
Other Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Receivables CAGR 3Y CAGR 5Y CAGR 10Y
S
Stille AB
STO:STIL
Other Receivables
kr36.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Elekta AB (publ)
STO:EKTA B
Other Receivables
kr1B
CAGR 3-Years
11%
CAGR 5-Years
10%
CAGR 10-Years
N/A
S
Surgical Science Sweden AB
STO:SUS
Other Receivables
kr31.1m
CAGR 3-Years
33%
CAGR 5-Years
60%
CAGR 10-Years
N/A
CellaVision AB
STO:CEVI
Other Receivables
kr26.5m
CAGR 3-Years
-10%
CAGR 5-Years
16%
CAGR 10-Years
10%
Getinge AB
STO:GETI B
Other Receivables
kr716m
CAGR 3-Years
-2%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Other Receivables
kr272m
CAGR 3-Years
-11%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
No Stocks Found

Stille AB
Glance View

Market Cap
1.8B SEK
Industry
Health Care

Stille AB engages in the development and sale of medical equipment. The company is headquartered in Torshaella, Sodermanlands. The product portfolio is divided into two business lines. The Surgery business area develops, produces and markets handcrafted, forged surgical instruments for all fields of open surgery, with an emphasis on cardiovascular surgery, and reconstructive and aesthetic plastic surgery. Its products include scissors, forceps, artery forceps, needle holders and clamps, among others. The Patient Positioning area develops and manufactures two main groups of procedure-specific specialized tables for cardiovascular surgery and gynecology, urology and urodynamic examinations. As of December 31, 2011, the Company had two wholly owned subsidiaries, Stille Surgical Inc. and Stille Incentive AB. As of December 30, 2011, the it's largest shareholder was Linc Invest AB (39.81%). On September 2, 2013, the Company sold its business unit, Sonesta, to ADDvise Lab Solutions publ AB.

STIL Intrinsic Value
286.89 SEK
Undervaluation 29%
Intrinsic Value
Price
S

See Also

What is Stille AB's Other Receivables?
Other Receivables
36.5m SEK

Based on the financial report for Sep 30, 2024, Stille AB's Other Receivables amounts to 36.5m SEK.

What is Stille AB's Other Receivables growth rate?
Other Receivables CAGR 1Y
1 016%

Over the last year, the Other Receivables growth was 1 016%.

Back to Top